10x Genomics (NASDAQ:TXG - Get Free Report) Director John Stuelpnagel sold 20,000 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $61.75, for a total transaction of $1,235,000.00. Following the sale, the director owned 328,436 shares in the company, valued at $20,280,923. This represents a 5.74% decrease in their position. The transaction was disclosed in a filing with the …